A recent study demonstrated that patients with COVID-19 have higher levels of VCAM-1 than controls with the same clinical presentation but without SARS-CoV-2 infection, supporting the concept that COVID-19-associated pneumonia specifically affects the endothelium (22). Here, VCAM1 is linked to susceptibility to pneumonia measurement.